Cartesian Therapeutics Inc. (RNAC) earnings · rev $2.8M
These earnings events as JSON? API free 100/dayCartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
This RNAC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RNAC revenue for 2025-12-31 was $2.8M. Net income was -$130.3M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. RNAC currently screens at market cap $290.9M.
When the next RNAC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 92.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RNAC research stays on the stock page; the tape stays on the quote page.
RNAC earnings FAQ
What are RNAC's latest revenue and net income?
Latest cached Cartesian Therapeutics Inc. (RNAC) revenue for Dec 31, 2025 was $2.8M. Net income was -$130.3M. Statements: https://lician.com/financials/rnac
What is RNAC's latest diluted EPS?
Latest cached Cartesian Therapeutics Inc. (RNAC) diluted EPS for Dec 31, 2025 was -$5.02.
What period does the latest RNAC earnings print cover?
The latest cached Cartesian Therapeutics Inc. (RNAC) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RNAC revenue change from the prior cached period?
Cached Cartesian Therapeutics Inc. (RNAC) revenue was down 92.8% from $38.9M (Dec 31, 2024) to $2.8M (Dec 31, 2025). Statements: https://lician.com/financials/rnac
Where are RNAC earnings listed?
Cached earnings facts for Cartesian Therapeutics Inc. (RNAC) are listed at https://lician.com/earnings/rnac. Statements: https://lician.com/financials/rnac
Not investment advice.